Oxford Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Oxford Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$225K	Buy	+3,707	New	+$216K	0.1%	315
2025 Q4	–	Sell	-47,603	Closed	-$2.15M	–	521
2025 Q3	$2.15M	Buy	+47,603	New	+$2.22M	0.71%	22
2024 Q3	–	Sell	-24,196	Closed	-$1M	–	325
2024 Q2	$1M	Buy	+24,196	New	+$1.08M	0.98%	18
2024 Q1	–	Sell	-20,713	Closed	-$1.06M	–	271
2023 Q4	$1.06M	Buy	+20,713	New	+$1.09M	1.59%	4
2020 Q1	–	Sell	-133,014	Closed	-$8.54M	–	357
2019 Q4	$8.54M	Buy	+133,014	New	+$7.62M	0.24%	91
2019 Q3	–	Sell	-72,390	Closed	-$10.9M	–	1718
2019 Q2	$10.9M	Buy	72,390 +21,115	+41%	+$984K	0.23%	75
2019 Q1	$10.4M	Sell	51,275 -93,239	-65%	-$4.64M	0.23%	82
2018 Q4	$7.51M	Sell	144,514 -19,005	-12%	-$1.02M	0.2%	121
2018 Q3	$10.1M	Buy	163,519 +150,770	+1,183%	+$8.95M	0.21%	94
2018 Q2	$707K	Sell	12,749 -46,354	-78%	-$2.5M	0.01%	1204
2018 Q1	$3.74M	Sell	59,103 -108,356	-65%	-$6.97M	0.08%	274
2017 Q4	$10.3M	Buy	167,459 +16,070	+11%	+$1.01M	0.22%	60
2017 Q3	$9.61M	Buy	+151,389	New	+$8.84M	0.19%	76

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Oxford Asset Management's BMY Position: Q1 2026 in Review

Oxford Asset Management opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 3,707 shares worth $225K. The stake represents 0.1% of the portfolio and ranks #315 among its holdings. This is a return to the name: Oxford Asset Management previously reported a position in BMY as recently as Q3 2025.

Oxford Asset Management first reported a position in BMY in Q3 2017 and has held it in 13 quarters since. The position peaked at $10.9M in Q2 2019. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Oxford Asset Management held 3,707 shares of Bristol-Myers Squibb worth $225K as of Q1 2026.
Bristol-Myers Squibb was a new Oxford Asset Management position in Q1 2026.
Bristol-Myers Squibb made up 0.1% of Oxford Asset Management's portfolio in Q1 2026, its #315 holding.
Oxford Asset Management first reported a position in Bristol-Myers Squibb in Q3 2017 and has held it in 13 quarters since.
Oxford Asset Management's Bristol-Myers Squibb position peaked at $10.9M in Q2 2019.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Oxford Asset Management's 13F filing for Q1 2026, filed 15 May 2026.